Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
Clinical trial NCT05183126 · RECRUITING
Trial details
- NCT number
- NCT05183126
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-28
- Primary completion
- 2026-11-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.